| Literature DB >> 35655155 |
Amir Valizadeh1, Mana Moassefi2, Amin Nakhostin-Ansari3, Seyed Hossein Hosseini Asl3,4, Mehrnush Saghab Torbati5, Reyhaneh Aghajani3,4, Zahra Maleki Ghorbani3,4, Shahriar Faghani6.
Abstract
OBJECTIVE: To evaluate the performance of the automated abstract screening tool Rayyan.Entities:
Keywords: Abstract screening; Methodology; Rayyan; Systematic reviews
Mesh:
Year: 2022 PMID: 35655155 PMCID: PMC9161508 DOI: 10.1186/s12874-022-01631-8
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.612
Fig. 1Summary of the screening process
Formulas for calculated metrics. FN False-negative, FP False-positive, NPV Negative predictive value, PPV Positive predictive value, SEN Sensitivity, SPE Specificity, TN True-negative, TP True-positive
Fig. 2Flow of records
Evaluation metrics for the test accuracy for identifying eligible records for the 3 SRs in each screening stage. Pooled results for each metric in each stage are presented below the results of the three SRs. Numbers in the parentheses indicate 95% CI. N/A Not available, NPV Negative predictive value, PPV Positive predictive value, PR Prevalence, SEN Sensitivity, SPE Specificity
Fig. 3Evaluation metrics for the test accuracy for identifying eligible records for the 3 SRs in each screening stage for a) a threshold of less than 2.5 for exclusion; b) a threshold of 2.5 and less for exclusion. NPV: Negative predictive value, PPV: Positive predictive value
Fig. 4Evaluation metrics for the test accuracy for identifying eligible records for the 3 SRs in each screening stage for a) a threshold of less than 2.5 for exclusion; b) a threshold of 2.5 and less for exclusion. NPV: Negative predictive value, PPV: Positive predictive value
Evaluation metrics for the test accuracy for identifying eligible reports for the 3 SRs in each screening stage. Pooled results for each metric in each stage are presented below the results of the three SRs. Numbers in the parentheses indicate 95% CI. N/A Not available, NPV Negative predictive value, PPV Positive predictive value, PR Prevalence, SEN Sensitivity, SPE Specificity
Fig. 5Evaluation metrics for the test accuracy for identifying eligible reports for the 3 SRs in each screening stage for a) a threshold of less than 2.5 for exclusion; b) a threshold of 2.5 and less for exclusion. NPV: Negative predictive value, PPV: Positive predictive value
Fig. 6Evaluation metrics for the test accuracy for identifying eligible reports for the 3 SRs in each screening stage for a) a threshold of less than 2.5 for exclusion; b) a threshold of 2.5 and less for exclusion. NPV: Negative predictive value, PPV: Positive predictive value
Summary of main findings. N/A Not available, SEN Sensitivity, SPE Specificity
Summary of the relevant studies. FNR: False-negative rate. SEN Sensitivity, SPE Specificity
| Olofsson 2017 [ | Rayyan [ | 3 SRs and 3 literature reviews | 7956 | SEN of 21-88% after screening 25% of records. SEN of 86-98% after screening 50% of records. SEN of 89-100% after screening 75% of records. | Thresholds used were not reported. SPE rates were not reported. |
| Rathbone 2015 [ | Abstrackr [ | 4 SRs | SR1: 1415 SR2: 517 SR3: 1735 SR4: 1042 | SR1: Precision of 16.8% and FNR of 10% after screening 18% of records. SR2: Precision of 24.7% and FNR of 14.5% after screening 23% of records. SR3: Precision of 29.2% and FNR of 4.7% after screening 7% of records. SR4: Precision of 45.5% and FNR of 2.4% after screening 12% of records. | SEN and SPE rates were not reported. |
| Gates 2018 [ | Abstrackr [ | 3 SRs and 1 descriptive analysis (DA) | SR1: 12763 SR2: 5893 SR3: 47385 DA: 5243 | SR1: SPE of 69% and SEN of 79% after screening 2.2% of records. SR2: SPE of 85% and SEN of 92% after screening 10.3% of records. SR3: SPE of 90% and SEN of 82% after screening 0.7% of records. DA: SPE of 19% and SEN of 96% after screening 4% of records. | – |
| Tsou 2020 [ | Abstrackr [ | 9 SRs | SR1: 9038 SR2: 3181 SR3: 2706 SR4: 889 SR5: 673 SR6: 651 SR7: 500 SR8: 427 SR9: 226 | For Abstrackr, SEN of 100% after screening 71.1, 51.5, 96, 95.6, 99, 85.9, 88.2, 99.3, and 93.8% of records for SR1 to SR9 respectively. For EPPI-Reviewer, SEN of 100% after screening 61.7, 39.9, 91.3, 94.6, 97.9, 86.3, 88.2, 98.8, and 91.6% of records for SR1 to SR9 respectively. | They also reported diagnostic metrics for identifying eligible reports. |
| Chai 2021 [ | Research Screener [ | 9 SRs and 2 scoping reviews (SCR) | SR1: 813 SR2: 2249 SR3: 2584 SR4: 368 SR5: 870 SR6: 306 SR7: 23423 SR8: 13376 SR9: 1686 SCR1: 16506 SCR2: 1230 | SEN of 100% after screening 32, 13, 6, 5, 4, 4, 5, 13, and 14% of records for SR1 to SR9 respectively. SEN of 100% after screening 40 and 38% of records for SCR1 to SCR2 respectively. | This tool utilizes deep learning algorithms. |
| Tsou 2020 [ | Abstrackr [ | 9 SRs | SR1: 696 SR2: 200 SR3: 843 SR4: 107 SR5: 267 SR6: 73 SR7: 166 SR8: 149 SR9: 104 | For Abstrackr, SEN of 100% after screening 40.7, 39.8, 81.2, 100, 71.6, 56.4, 41.2, 60, and 71.2% of eligible records for SR1 to SR9 respectively. For EPPI-Reviewer, SEN of 100% after screening 41, 39.8, 97.1, 70, 74, 30.1, 31.8, 59.4, and 51.3% of eligible records for SR1 to SR9 respectively. | |